acute coronary syndrome

This page shows the latest acute coronary syndrome news and features for those working in and with pharma, biotech and healthcare.

AZ says Brilinta hits the mark in diabetic heart disease

territory. Meanwhile, next year, AZ is also expecting a phase 3 readout in the THALES trial of Brilinta as a treatment for in acute ischemic stroke and transient ischaemic attack, that ... patients undergoing interventions for acute coronary syndrome (ACS

Latest news

Cancer drugs and China sustain AZ’s return to growth

antiplatelet drug Brilinta (ticagrelor) rose 22% to $1.32bn thanks to continued market penetration in the treatment of acute coronary syndrome (ACS) and high-risk post-myocardial infarction patients.
Novartis and Bayer among backers for European big data project

Its overarching aim is to improve patient outcomes and reduce the burden on society of atrial fibrillation (AF), heart failure (HF) and acute coronary syndrome (ACS).
Another failed trial knocks back AZ's plan to grow Brilinta

Putting a brave face on the verdict, AZ's chief medical officer Sean Bohen said that the "proven benefits of Brilinta in acute coronary syndrome and post-myocardial infarction patients are
AZ's Brilinta disappoints in stroke trial

its approval in its current indication in acute coronary syndrome (ACS).
AstraZeneca wins EU approvals for Zurampic and Brilique

A 90mg dose of Brilique is already available in the EU for adults with acute coronary syndrome (ACS), but the approval of a 60mg dose means that patients with a history

More from news
Approximately 7 fully matching, plus 48 partially matching documents found.

Latest Intelligence

Why health psychology is the answer to tackling adherence

In one recent programme that we developed on behalf of AstraZeneca, we assessed the reasons for low adherence in patients with acute coronary syndrome (ACS) who had been prescribed Oral Antiplatelet

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

AZ names Brilique lead in Spain

In this role Gribble will be responsible for the company's marketing of Brilique (ticagrelor) for acute coronary syndrome, including management, development and market access activities, and he will also be ... to save the lives of thousands of people

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

Dissecting adherence to personalise patient support

Molloy, G, et al. (2014). Intentional and unintentional non-adherence to medications following an acute coronary syndrome: a longitudinal study.
Understanding the "Big Picture"

A good example would be in acute coronary syndrome (ACS) where there is data to suggest that approximately 350, 000 males in the USA currently suffer from this syndrome.

More from PMHub
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

EU Head of Business Development and Client Service: Exceptional packge and bonus

Programme/ Account Director - Healthcare PR - London: Salary TBC

Senior Account Executive – Account Manager – Healthcare Advertis...: £32000 - £43000 Bonus Benfits

Account Manager, Medical Communications and Marketing: £30, 000 – £40, 000 benefits and bonus

Home based, Senior Medical Writer, Medical Communications: Excellent package

Health Consultant - Brand Comms: Competitive Salary

Home-based Medical Writer – Medical Education: Salary TBC

AM – Corporate Comms/ Public Affairs/ B2B – Healthcare Focus: Salary TBC

PRINCIPAL MEDICAL WRITER > ETL - LONDON / NEW YORK/ HOME - ME...: Salary TBC

Managing Director – Global Medical Writing & Scientific Exce...: £120-150K

Scientific Director – Medical Communications - New York or Remot...: $100000 - $150000

Science writer, Healthcare Brand Communications, London, £45-50K...: £45-50K

Freelance Senior Account Manager / Account Director - Healthcare...: £350-400 depending on experience

Account Director, Medical Education: Salary TBC

Digital Account Director: Salary TBC

Science Writer, Healthcare Advertising Agency: £40, 000 - 45, 000 DOE benefits,

Senior Medical Writer: Salary TBC

Chief Medical Writer, Medical Communications, London, up to £90K...: up to £90K

Senior Account Manager, Medical Communications, London: Excellent package

Creative/ Medical Writer: Circa £35, 000 With Benefits

Home-based Senior Medical Writer – Med Ed: Salary TBC

Senior Account Director – Healthcare Advertising – London: Salary TBC

Scientific Director – Medical Communications: Salary TBC

Senior Digital Health Specialist – Global Agency: Salary TBC

Freelance AM/ AD Healthcare Advertising: £350-400 depending on experience

Subscribe to our email news alerts

PMHub

Add my company

Six Degrees Medical Consulting

For over a decade, our medical communication services have helped pharmaceutical companies optimize their brand, disease and corporate objectives. Building...